BPA for iclusig

Ended Awarded Last action

Contract number
36E79720A0001
Awardee
Awarding agency
Task orders
3 $119,522 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$119,522 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 1% used
$13,204,755.65
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, under the company's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The single-award BPA, valued at over $13 million, is for the supply of the oncology medication ICLUSIG (ponatinib) to various VA Medical Centers and Veterans Integrated Service Networks (VISNs) nationwide. This long-term agreement demonstrates Takeda's established relationship with the VA as a key supplier of critical pharmaceuticals to support the healthcare needs of veterans.

The VA has also awarded several firm fixed price BPA call orders to Takeda Pharmaceuticals America under this overarching BPA. These task orders, ranging from approximately $22,000 to $57,000, are for the delivery of emergency oncology medications such as ICLUSIG and NINLARO (ixazomib) to VA facilities in different regions, including VISN 2 (New York and Pennsylvania) and VISN 22 (Southwestern U.S.). The contracts have no set-aside designations, reflecting Takeda's status as a large, foreign-owned business, and call for performance at the company's facility in Earth City, Missouri.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 · Iclusig ordering form update $0
Supplemental Agreement for work within scope P00011 · 2024 public law price updates $0
Exercise an Option P00010 · Exercise option year 4 $0
Supplemental Agreement for work within scope P00009 · 2023 public law pricing updates $0
Other Administrative Action P00008 · Company name change from millennium pharmaceuticals, INC. To takeda pharmaceuticals america, INC. $0
Exercise an Option P00007 · Exercise the 3RD option year on BPA 36E79720A0001 $0
Supplemental Agreement for work within scope P00006 · 2022 public law pricing updates $0
Exercise an Option P00005 · Exercise option year 2 for iclusig. $0
Supplemental Agreement for work within scope P00004 · Product addition - iclusig $0
Supplemental Agreement for work within scope P00003 · 2021 public law pricing updates $0
Exercise an Option P00002 · Exercise option year 1. $0
Supplemental Agreement for work within scope P00001 · 2020 public law pricing updates $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79720A0001?

36E79720A0001 was awarded to Takeda Pharmaceuticals America, Inc. by National Acquisition Center (Headquarters) on October 4, 2019.

How much is contract 36E79720A0001 worth?

Orders under 36E79720A0001 have obligated $119,522. 36E79720A0001's own ceiling is $13,204,756.

How many orders have been placed under contract 36E79720A0001?

3 orders have been placed under 36E79720A0001, the latest on August 3, 2023.

Who can order from contract 36E79720A0001?

36E79720A0001 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79720A0001 under another contract?

Yes. 36E79720A0001 is a blanket purchase agreement under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79720A0001 competed?

The extent of competition for 36E79720A0001 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV